Jahan TM - Search Results

1

Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.

Wu SY, Lazar AA, Gubens MA, Blakely CM, Gottschalk AR, Jablons DM, Jahan TM, Wang VEH, Dunbar TL, Wong ML, Chan JW, Guthrie W, Belkora J, Yom SS. Wu SY, et al. Among authors: jahan tm. JAMA Netw Open. 2020 Sep 1;3(9):e209750. doi: 10.1001/jamanetworkopen.2020.9750. JAMA Netw Open. 2020. PMID: 32997124 Free PMC article. Clinical Trial.

2

Emerging antiangiogenic therapies for non-small-cell lung cancer.

Blakely C, Jahan T. Blakely C, et al. Expert Rev Anticancer Ther. 2011 Oct;11(10):1607-18. doi: 10.1586/era.11.146. Expert Rev Anticancer Ther. 2011. PMID: 21999134 Review.

3

Mechanisms of and potential treatment strategies for metastatic disease in non-small cell lung cancer.

Maslyar DJ, Jahan TM, Jablons DM. Maslyar DJ, et al. Among authors: jahan tm. Semin Thorac Cardiovasc Surg. 2004 Spring;16(1):40-50. doi: 10.1053/j.semtcvs.2003.12.003. Semin Thorac Cardiovasc Surg. 2004. PMID: 15366686 Review.

4

Implications of delayed initiation of radiotherapy: accelerated repopulation after induction chemotherapy for stage III non-small cell lung cancer.

Chen CP, Weinberg VK, Jahan TM, Jablons DM, Yom SS. Chen CP, et al. Among authors: jahan tm. J Thorac Oncol. 2011 Nov;6(11):1857-64. doi: 10.1097/JTO.0b013e318229a41e. J Thorac Oncol. 2011. PMID: 21964528 Free article.

5

Adjuvant Chemotherapy Guided by Molecular Profiling and Improved Outcomes in Early Stage, Non-Small-Cell Lung Cancer.

Woodard GA, Wang SX, Kratz JR, Zoon-Besselink CT, Chiang CY, Gubens MA, Jahan TM, Blakely CM, Jones KD, Mann MJ, Jablons DM. Woodard GA, et al. Among authors: jahan tm. Clin Lung Cancer. 2018 Jan;19(1):58-64. doi: 10.1016/j.cllc.2017.05.015. Epub 2017 May 31. Clin Lung Cancer. 2018. PMID: 28645632

6

Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain.

Chen AM, Jahan TM, Jablons DM, Garcia J, Larson DA. Chen AM, et al. Among authors: jahan tm. Cancer. 2007 Apr 15;109(8):1668-75. doi: 10.1002/cncr.22565. Cancer. 2007. PMID: 17342770 Free article.

7

Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans.

Wang S, Wong ML, Hamilton N, Davoren JB, Jahan TM, Walter LC. Wang S, et al. Among authors: jahan tm. J Clin Oncol. 2012 May 1;30(13):1447-55. doi: 10.1200/JCO.2011.39.5269. Epub 2012 Mar 26. J Clin Oncol. 2012. PMID: 22454424 Free PMC article.

8

Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung cancer.

Woodard GA, Gubens MA, Jahan TM, Jones KD, Kukreja J, Theodore PR, Cardozo S, Jew G, Clary-Macy C, Jablons DM, Mann MJ. Woodard GA, et al. Among authors: jahan tm. Clin Lung Cancer. 2014 Nov;15(6):426-32. doi: 10.1016/j.cllc.2014.07.004. Epub 2014 Aug 15. Clin Lung Cancer. 2014. PMID: 25258195

9

Incorporation of a Molecular Prognostic Classifier Improves Conventional Non-Small Cell Lung Cancer Staging.

Kratz JR, Haro GJ, Cook NR, He J, Van Den Eeden SK, Woodard GA, Gubens MA, Jahan TM, Jones KD, Kim IJ, He B, Jablons DM, Mann MJ. Kratz JR, et al. Among authors: jahan tm. J Thorac Oncol. 2019 Jul;14(7):1223-1232. doi: 10.1016/j.jtho.2019.03.015. Epub 2019 Apr 5. J Thorac Oncol. 2019. PMID: 30959120 Free article.

10

Stage II (N1) lung cancer.

Choy O, Jahan T, Roach M 3rd, You L, Jablons D. Choy O, et al. Chest Surg Clin N Am. 2001 Feb;11(1):39-59, viii. Chest Surg Clin N Am. 2001. PMID: 11253600 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page